شکل دارویی : کپسول (حاوی 0.4 میلیگرم تامسولوسین +0.5 ملیگرم دوتاستراید)
بسته بندی : بسته 30 عددی
نام ژنریک : تامسولوسین +دوتاستراید
دسته دارویی : داروهای انتخابی مهارکننده آلفا۱ آدرنرژیک
سازنده: شرکت داروسازی اکتوور
The results of the CombAT (combination of dutasteride (Avodart) and tamsulosin, under the brand name Duodart) trial in 2008 demonstrated that treatment with the combination of dutasteride and tamsulosin provides greater symptom benefits compared to monotherapy with either agent alone for treatment of benign prostatic hyperplasia. The CombAT trial became the medication Jalyn. It was approved by the FDA on 14 June 2010 This combination can be useful because it may take up to six months for symptomatic relief to be found when using 5-alpha-reductase inhibitors such as dutasteride compared to alpha-1 receptor blockers, which can provide relief in some cases within 48 hour